BioCentury
ARTICLE | Financial News

Innate Immunotherapeutics proposes IPO

December 9, 2013 8:00 AM UTC

Innate Immunotherapeutics Ltd., Auckland, New Zealand Business: Autoimmune, Cancer, Infectious Date announced: 11/26/13 Type: IPO To be raised: Up to A$12 million ($11 million) Shares: 60 million Pric...